Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2Phase 3 Interventional

A Clinical Trial of PRAX-114 in Participants With Major Depressive Disorder

ClinicalTrials.gov ID: NCT04832425

Public ClinicalTrials.gov record NCT04832425. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 6, 2026, 1:47 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2/3 Double-Blind, Placebo-Controlled Clinical Trial to Evaluate the Efficacy and Safety of PRAX-114 in Participants With Major Depressive Disorder

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a randomized, double-blind, placebo-controlled clinical trial to assess the efficacy and safety of PRAX-114 in participants with moderate to severe major depressive disorder (MDD). Participants will be randomized to receive 28 days of either 40 mg PRAX-114 or placebo in a 1:1 ratio.

Study identification

NCT ID
NCT04832425
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2, Phase 3
Lead sponsor
Praxis Precision Medicines
Industry
Enrollment
216 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 30, 2021 (Actual)
Primary completion
May 5, 2022 (Actual)
Completion
May 5, 2022 (Actual)
Last update posted
Jul 21, 2022

2021 – 2022

United States locations

U.S. sites
30
U.S. states
17
U.S. cities
30
Facility City State ZIP Site status
Praxis Research Site Phoenix Arizona 85012 —
Praxis Research Site Garden Grove California 92845 —
Praxis Research Site Lafayette California 94549 —
Praxis Research Site Lemon Grove California 91945 —
Praxis Research Site Oceanside California 92056 —
Praxis Research Site Pico Rivera California 90660 —
Praxis Research Site Redlands California 92374 —
Praxis Research Site Jacksonville Florida 32256 —
Praxis Research Site Orange City Florida 32763 —
Praxis Research Site Orlando Florida 32801 —
Praxis Research Site Atlanta Georgia 30331 —
Praxis Research Site Decatur Georgia 30030 —
Praxis Research Site Chicago Illinois 60076 —
Praxis Research Site Gaithersburg Maryland 20877 —
Praxis Research Site Worcester Massachusetts 01655 —
Praxis Research Site O'Fallon Missouri 63368 —
Praxis Research Site Las Vegas Nevada 89102 —
Praxis Research Site Berlin New Jersey 08009 —
Praxis Research Site Marlton New Jersey 08053 —
Praxis Research Site Cedarhurst New York 11516 —
Praxis Research Site Rochester New York 14618 —
Praxis Research Site Staten Island New York 10312 —
Praxis Research Site Dayton Ohio 45417 —
Praxis Research Site Allentown Pennsylvania 18104 —
Praxis Research Site Media Pennsylvania 19063 —
Praxis Research Site Memphis Tennessee 38119 —
Praxis Research Site Austin Texas 78737 —
Praxis Research Site San Antonio Texas 78229 —
Praxis Research Site Charlottesville Virginia 22903 —
Praxis Research Site Everett Washington 98201 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04832425, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 21, 2022 · Synced Nov 6, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT04832425 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →